Clinical Trials Browser

OTHER × Waldenstrom Macroglobulinemia × acalabrutinib × Clear all

NCT04624906 2026-02-04

BRAWM

Phase 2 Active not recruiting

Waldenstrom Macroglobulinemia

NCT05065554 2025-12-05

ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy

Phase 2 Active not recruiting

Waldenstrom Macroglobulinemia, Neuritis